Russian Heart Failure Journal 2011year Resynchronizing therapy for CHF patients


To access this material please log in or register

Register Authorize
2011/

Resynchronizing therapy for CHF patients

Mareyev Yu. V.
Federal State Budgetary Institution, “Russian Cardiology Research and Production Complex” of the RF Ministry of Health Care, 3rd Cherepkovskaya 15a, Moscow 121552

Keywords: resynchronization therapy, CHF

DOI: 10.18087/rhfj.2011.5.1578

Review presents research data that formed the modern conception concerning efficiency of heart resynchronizing therapy.
  1. Braunwald E. The management of heart failure: the past, the present and the future. Circ Heart Fail. 2008 May; 1 (1):58–62.
  2. Katz A. The «modern» view of heart failure. How did we get here. Circ Heart Fail. 2008;1 (1):63–71.
  3. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341 (10):709–717.
  4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316 (23):1429–1435.
  5. Heidenreich PA, Lee TT, Massie BM et al. Effect of beta-blockade onmortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30 (1):27–34.
  6. Felker G, O’Conner C. Inotropic therapy for heart failure: an evidence-based approach. Am Heart J. 2001;142 (3):393–401.
  7. Adams KF Jr, Gheorghiade M, Uretsky BF et al. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol. 2002;39 (6):946–953.
  8. Беленков Ю. Н., Мареев В. Ю. Лечение сердечной недостаточности в XXI веке: достижения, вопросы и уроки доказательной медицины. Кардиология 2008;48 (2):6–16.
  9. Wiggers CJ. The muscular reactions of the mammalian ventricles to artificial surface stimuli. Am J Physiol 1925;73:346–78.
  10. Padeletti L, Giaccardi M, Turreni F et al. Influence of QRS prolongation on the natural history of CHF. Eur Heart J Suppl 6 (2004):D79.
  11. Yellin EL, Nikolic S, Frater RW et al. Left ventricular filling dynamics and diastolic function. Prog Cardiovasc Dis. 1990;32 (4):247–271.
  12. Murkofsky RL, Dangas G, Diamond JA et al. A prolong QRS duration on surface electrocardiogram is specific indicator of legt ventricular dysfunction. J Am Coll Cardiol. 1998;32 (2):476–482.
  13. Gottipaty VK, Krelis SP, Lu F et al. The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure. J Am Coll Cardiol. 1999;33 (Suppl A):145A.
  14. Wilkoff BL, Cook JR, Epstein AE et al. The DAVID trial investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002 Dec 25;288 (24):3115–23.
  15. Yu CM, Chan JY, Zhang Q et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med. 2009;361 (22):2123–2134.
  16. Humphries JO, Hinman EJ, Bernstein L, Walker WG. Effect of artificial pacing of the heart on cardiac and renal function. Circulation. 1967;36 (5):717–723.
  17. Heldman D, Mulvihill D, Nguyen H et al. True incidence of pacemaker syndrome. Pacing Clin Electrophysiol. 1990;13 (12 Pt 2):1742–1750.
  18. Hochleitner M, Hörtnagl H, Ng CK et al. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol. 1990;66 (2):198–202.
  19. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol. 1995;26 (4):967–973.
  20. Cazeau S, Ritter P, Bakdach S et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol. 1994;17 (11 Pt 2):1974–1979.
  21. McAlister FA, Ezekowitz JA, Wiebe N et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med. 2004;141 (5):381–390.
  22. Carson P, Anand I, O’Connor C et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol. 2005;46 (12):2329–2334.
  23. Cleland JG, Daubert JC, Erdmann E et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27 (16):1928–1932.
  24. Nelson GS, Berger RD, Fetics BJ et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102 (25):3053–3059.
  25. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352 (15):1539–1549.
  26. Chung ES, Leon AR, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117 (20):2608–2016.
  27. Auricchio A, Stellbrink C, Butter C et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42 (12):2109–2116.
  28. Moss AJ, Hall WJ, Cannom DS et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361 (14):1329–1338.
  29. Cleland J, Freemantle N, Ghio S et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol. 2008;52 (6):438–445.
  30. Price DJ, Wallbridge DR, Stewart MJ. Tissue Doppler imaging: current and potential clinical applications. Heart. 2000;84 (Suppl 2):II11–18.
  31. Cazeau SJ, Daubert JC, Tavazzi L et al. Responders to cardiac resynchronization therapy with narrow or intermediate QRS complexes identified by simple echocardiographic indices of dyssynchrony: the DESIRE study. Eur J Heart Fail. 2008;10 (3):273–280.
  32. van Bommel RJ, Bax JJ, Abraham WT et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009;30 (20):2470–2477.
  33. Chung ES, Leon AR, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117 (20):2608–2616.
  34. Kapetanakis S, Bhan A, Murgatroyd F et al. Real-time 3D echo in patient selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2011;4 (1):16–26.
  35. Teske AJ, De Boeck BW, Melman PG et al. Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking. Cardiovasc Ultrasound. 2007;5:27.
  36. Ypenburg C, Schalij MJ, Bleeker GB et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischemic heart failure patients. Eur Heart J. 2007;28 (1):33–41.
  37. Bleeker GB, Kaandorp TA, Lamb HJ et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113 (7):969–976.
  38. Díaz-Infante E, Mont L, Leal J et al. SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol. 2005;95 (12):1436–1440.
  39. Mullens W, Grimm RA, Verga T et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009;53 (9):765–773.
  40. Tang AS, Wells GA, Talajic M et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363 (25):2385–2395.
Mareyev Yu.V. Resynchronizing therapy for CHF patients. Russian Heart Failure Journal. 2011;12(5):297-301.

To access this material please log in or register

Register Authorize
Ru En